LEO PHARMA UK AND IRELAND


WE HELP PEOPLE ACHIEVE HEALTHY SKIN

As a leader in medical dermatology with a robust pipeline, a wide range of therapies, and a pioneering spirit, LEO Pharma's purpose is to make a true difference to the lives of people living with skin diseases.

Established globally, LEO Pharma has a proven track record of pioneering solutions in treatment areas spanning, plaque psoriasis, atopic dermatitis, acne and actinic keratosis.

LEO Pharma is committed to helping 125 million people by 2025. As long as there is a patient out there needing our help, we carry on our mission.


PARTNERSHIPS

LEO Pharma believes in developing powerful partnerships with a range of stakeholders in order to drive innovation; heighten education and improve patient outcomes.

We collaborate with the NHS, academic institutions, research centres, healthcare professionals and the private sector worldwide.

We view these relationships as driven by a shared commitment to look beyond today to constantly improve and extend what's possible for people living with skin conditions.

"LEO Pharma were instrumental in the formation of the Primary Care Dermatology Society back in 1994 and have supported the Society since that time."
- Siobhan Wastie, Commercial Director, Primary Care Dermatology Society (PCDS)

"For over 30 years, I have had only positive experiences with LEO Pharma. The high professional standards demonstrated by everyone from the company I have had dealings with, are only to be admired, e.g. services and support programmes such as QualityCareTM. Patient safety, efficacy and satisfaction remain a high priority."
- Professor Rino Cerio, Consultant, Dermatologist, Barts Health NHS Trust
"LEO Pharma, being a Foundation rather than a shares-dependent company, have been brilliant at supporting medical education for Dermatology Health Care Professionals. The educational grants provided by LEO Pharma have been invaluable in supporting psychodermatology training when no such course existed."
- Dr Anthony Bewley, Consultant Dermatologist, Barts Health NHS Trust

WE ARE PIONEERING

WE LOOK BEYOND TODAY TO CONSTANTLY IMPROVE AND EXTEND WHAT'S POSSIBLE FOR THE BENFIT OF PATIENTS

Since 1991, the launch of our first plaque psoriasis treatment we have pioneered approaches including: combining two previously unmixable active ingredients; varying methods of application and creating new formulations to suit a range of patient and prescriber needs.
We draw upon our heritage and expertise in dermatology to research modern treatment options, including 'systemics' (treatments that reach cells throughout the body by travelling through the blood stream) and 'biologics' (treatment that uses substances from living organisms).
As part of the LEO Pharma 2025 strategy, we aim to advance innovation and access to potential therapies for patients with life-altering conditions and rare diseases. Our ambition is to launch two new treatments for rare diseases globally by 2025.

WE PUT PEOPLE LIVING WITH SKIN CONDITIONS
AT HEART OF EVERYTHING WE DO

We listen to people about the impact of living with the conditions we aim to treat. We involve patients at the early stages of our research and development programmes.

Through long-term relationships with a range of stakeholder groups, we strive to help healthcare professionals in the UK and Ireland deliver the best possible care for patients.

DERMATOLOGY BEYOND THE SKIN:
INITIATIVES THAT WE ARE PROUD OF...

01

The Voices in Partnership (ViP) programme, bringing together people living with skin conditions, so helping us to better understand the day-to-day impact of having a skin condition

02

Partnership with the Patients Association on the PSO What? Report raising awareness of the real impact psoriasis has on people's lives and gaps in continuity of care

03

Multi-award-winning campaign 'Give Nothing To Psoriasis', empowering those living with psoriasis to make positive changes and not to give up' aspects of their lie to the condition

04

20,000 visitors from the UK and Ireland to our QualityCareTM resource that provides support for people living with psoriasis each month

05

Industry Dermatology Initiative (IDI), LEO Pharma is part of a group of companies dedicated to working with the NHS to optimise the care of people living with conditions. The group exists to work collaboratively with stakeholders across the field of dermatology to complement existing work streams in this area

06

350,000 engagements with LEO pharma social channels

OUR COMMITMENT

LEO Pharma will continue to work relentlessly to further strengthen patient voices, develop our partnerships with patient advocacy, and support patients in getting access to the dermatology care they need. The collective skills and efforts from everyone at LEO Pharma and our partners are the basis for our success. We continue on the path we've chartered for more than 110 years -building, sharing and reinvesting in knowledge.

Let's pioneer together.

KEEP IN TOUCH

Twitter: @LEOPharmaUKIE Instagram: @leopharmaukie Facebook: Facebook.com/LEOPharmaUKIE YouTube: LEO Pharma UK/IE Email: medical-info.uk@leo-pharma.com Quality CareTM: psoriasis.qualitycarebyleo.com Produced by LEO Pharma

May 2020 | UK/IE/MAT-25668